Budesonide Oral Inhalation
221 interactions 609 cited referencesBudesonide is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma. Budesonide powder for oral inhalation (Pulmicort Flexhaler) is used in adults and children 6 years of age and older. Budesonide suspension (liquid) for oral inhalation (Pulmicort Respules) is used in children 1… Read the full Budesonide Oral Inhalation drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Budesonide Oral Inhalation Insulin Aspart, Recombinant Fiasp Reduced blood glucose lowering effect of insulin Details Budesonide Oral Inhalation Insulin Glargine, Recombinant Basaglar Reduced blood glucose lowering effect of insulin Details Budesonide Oral Inhalation Insulin Icodec-Abae Awiqli Reduced efficacy of insulin icodec-abae Details Budesonide Oral Inhalation Itraconazole Sporanox Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Ivacaftor Kalydeco Increased budesonide exposure Details Budesonide Oral Inhalation Ivosidenib Tibsovo Reduced exposure of sensitive CYP3A4 substrates and risk of loss of efficacy Details Budesonide Oral Inhalation Ketoconazole Extina Increased budesonide exposure Details Budesonide Oral Inhalation Ketoprofen Actron® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Ketorolac Acular Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Larotrectinib Increased sensitive CYP3A4 substrate exposure and increase in the incidence or severity of adverse reactions Details Budesonide Oral Inhalation Lefamulin Xenleta Increased sensitive CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related toxicities associated wi... Details Budesonide Oral Inhalation Lenacapavir Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of Cushing's syndrome and adrenal suppression Details Budesonide Oral Inhalation Letermovir Prevymis Increased budesonide exposure Details Budesonide Oral Inhalation Levofloxacin Levaquin An increased risk of tendon rupture Details Budesonide Oral Inhalation Lomefloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Lomitapide Increased budesonide exposure Details Budesonide Oral Inhalation Lonafarnib Zokinvy Increased budesonide exposure Details Budesonide Oral Inhalation Lornoxicam Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Loxoprofen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Lumacaftor Reduced exposure to CYP3A substrate Details Budesonide Oral Inhalation Lumiracoxib Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Lutetium Lu 177 Dotatate Decreased lutetium Lu 177 dotatate efficacy Details Budesonide Oral Inhalation Macimorelin False-positive or false-negative adult growth hormone deficiency diagnosis Details Budesonide Oral Inhalation Maribavir Livtencity Increased budesonide exposure Details Budesonide Oral Inhalation Meclofenamate Meclodium® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Mefenamic Acid Ponstel® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Meloxicam Alloxate Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Mitapivat Aqvesme Reduced CYP3A substrate exposure Details Budesonide Oral Inhalation Morniflumate Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Moxifloxacin Avelox An increased risk of tendon rupture Details Budesonide Oral Inhalation Nabumetone Relafen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Nadifloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Nadroparin Increased risk of bleeding Details Budesonide Oral Inhalation Naproxen Aleve Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Nefazodone Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Nelfinavir Viracept Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Nepafenac Ilevro Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Netupitant Increased exposure of CYP3A4 substrate Details Budesonide Oral Inhalation Niflumic Acid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Nilotinib Increased budesonide exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist